No Data
No Data
Walvax Biotechnology (300142.SZ) appointed Wu Changxiong as the Chief Financial Officer.
Walvax Biotechnology (300142.SZ) announced that the board of directors has approved the appointment of Mr. Wu Changxiong as the company's Chief Financial Officer.
We Think Walvax Biotechnology (SZSE:300142) Can Stay On Top Of Its Debt
Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology
On June 26th, A-share lightning rod: Feiwo Technology - Hunan Wenyi plans to reduce its shareholding by no more than 1.00%; ST Shenzhen Universe: the stock may face the risk of delisting.
Shareholder Hunan Tourist is planning to reduce its shareholding in Feiwo Technology by no more than 1.00%; There is a risk that the stock of Shenzhen Universe may be delisted; Walvax Biotechnology and Eibo terminated their agreement on the COVID-19 and shingles mRNA vaccines.
Walvax Biotechnology (300142.SZ): Terminates COVID-19 and herpes zoster mRNA vaccine technology development cooperation with Eibo Biotechnology.
Walvax Biotechnology (300142.SZ) released a statement announcing the convening of the fifth Board of Directors on June 24, 2024 ...
Express News | Walvax Biotechnology Says It, Unit to Terminate Clinical Trial of Mrna Vaccines Jointly Developed With Suzhou Abogen Biosciences
No Data